Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1466
Peer-review started: January 6, 2024
First decision: January 16, 2024
Revised: January 23, 2024
Accepted: February 25, 2024
Article in press: February 25, 2024
Published online: March 14, 2024
Processing time: 67 Days and 19.4 Hours
For ulcerative colitis (UC), the variability in inflammatory activity along the colon poses a challenge in management. The focus on achieving endoscopic healing in UC is evident, where the UC Endoscopic Index of Severity and Mayo Endoscopic Subscore are commonly used for evaluation. However, these indices primarily consider the most severely affected region. Liu et al recent study validates the Toronto Inflammatory Bowel Disease Global Endoscopic Reporting (TIGER) score offering a comprehensive assessment of inflammatory activity across diverse segments of the colon and rectum and a reliable index correlating strongly with UC Endoscopic Index of Severity and moderately with Mayo Endoscopic Subscore (MES). Despite recommendation, certain aspects warrant further investigation. Fecal calprotectin, an intermediate target, correlates with TIGER and should be explored. Determining TIGER scores defining endoscopic remission and response, evaluating agreement with histological activity, and assessing inter-endoscopist agreement for TIGER require scrutiny. Exploring the correlation between TIGER and intestinal ultrasound, akin to MES, adds value.
Core Tip: For ulcerative colitis (UC), the degree of inflammatory activity can vary along the length of the colon, ranging from the rectum to the proximal colon. Currently, achieving endoscopic healing is a long-term goal in the management of UC, with the UC Endoscopic Index of Severity score and Mayo Endoscopic Subscore being the most suggested indices to evaluate this target. However, both scores only consider the most severely affected area in their final assessment. Recently, the Toronto Inflammatory Bowel Disease Global Endoscopic Reporting score has shown its usefulness in determining the extent and severity of inflammatory activity across various segments of the colon and rectum. Despite this, there is no consensus regarding the endoscopic method (total colonoscopy or sigmoidoscopy) for evaluating the achievement of endoscopic healing in UC patients.